Letters to the Editor
Vol. 15 No. 1 (2023)
https://doi.org/10.4081/dr.2022.9535

Prolonged impact of COVID-19 pandemic on delayed melanoma diagnosis: further data based on one-year appraisal from Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 7 July 2022
852
Views
322
Downloads
17
HTML
Melanoma, Covid-19

Authors

Calogero Pagliarello
calogero.pagliarello@libero.it
https://orcid.org/0000-0001-7169-4829
UO Multizonale Dermatologia Ospedale Santa Chiara, Trento, Italy.
Mariacristina Sicher
UO Multizonale Dermatologia Ospedale Santa Chiara, Trento, Italy.
Carlo Renè Girardelli
UO Multizonale Dermatologia Ospedale Santa Chiara, Trento, Italy.
Ignazio Stanganelli
Dermatology Unit, Department of Medicine and Surgery, University of Parma, Parma; Skin Cancer Unit IRCCS IRST, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

Not available.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Ricci F, Fania L, Paradisi A, et al. Delayed melanoma diagnosis in the COVID-19 era: increased breslow thickness in primary melanomas seen after the COVID-19 lockdown. J Eur Acad Dermatol Venereol 2020 Dec;34:e778-e779.
Marson JW, Maner BS, Harding TP et al. The magnitude of COVID-19’s effect on the timely management of melanoma and nonmelanoma skin cancers. J Am Acad Dermatol 2021;84:1100-3
Lallas A, Kyrgidis A, Manoli SM et al. Delayed skin cancer diagnosis in 2020 because of the COVID-19-related restrictions: data from an institutional registry. J Am Acad Dermatol 2021.
Gisondi P, Cazzaniga S, Di Leo S, et al. Impact of the COVID-19 pandemic on melanoma diagnosis. J Eur Acad Dermatol Venereol 2021.
Lo Bello G, Pini GM, Ferguglia G, et al. Effects of COVID-19 restriction measures and clinical resetting on delayed melanoma diagnosis: a single Institution experience. Ital J Dermatol Venerol 2021.
Koch E, Villanueva F, Marchetti MA et al. Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study. J Eur Acad Dermatol Venereol 2021.

How to Cite



1.
Pagliarello C, Sicher M, Girardelli CR, Stanganelli I. Prolonged impact of COVID-19 pandemic on delayed melanoma diagnosis: further data based on one-year appraisal from Italy. Dermatol Reports [Internet]. 2022 Jul. 7 [cited 2026 May 19];15(1). Available from: https://journals.pagepress.net/dr/article/view/9535
Copyright (c) 2022 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.